Schwarzmayr Ludwig, Andorfer Peter, Novy Michael, Rotheneder Hans
Max F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, Dr. Bohr-Gasse 9/2, A-1030 Vienna, Austria.
Int J Biochem Cell Biol. 2008;40(12):2845-53. doi: 10.1016/j.biocel.2008.06.001. Epub 2008 Jun 8.
The E2F-associated phosphoprotein (EAPP) is a ubiquitous nuclear protein that interacts with the activating members of the E2F family of transcription factors and increases the activity of several cell-cycle regulated promoters in an E2F-dependent manner. Our previous studies also showed that EAPP levels are elevated in most transformed human cells. To examine the molecular basis of this increase of EAPP we isolated and studied the nucleotide sequence at the 5' end of the EAPP gene. In silico analysis revealed a TATA-less promoter with several putative binding sites for transcription factors, the most probable ones being Sp1, Sp3 and Egr-1. We could confirm the binding of these factors in vitro by electrophoretic mobility shift assays, supershift experiments and competition assays. Additionally we could validate the binding in vivo by chromatin-immunoprecipitation assays. To analyse the function of these transcription factors in the expression of EAPP, we performed reporter-assays with the promoter and truncations thereof. We found that Sp1 and Egr-1 stimulate the EAPP promoter, whereas Sp3 acts as a repressor that could even overcome the positive effect of the activators. Increasing the amounts of Sp3 also caused a strong reduction of EAPP, but the overexpression of Sp1 or Egr-1 resulted in only marginally higher EAPP levels. Our results suggest that the elevated EAPP levels in transformed cells can be caused by reduced Sp3 activity, but higher Sp1 activity might also play a role.
E2F相关磷蛋白(EAPP)是一种普遍存在的核蛋白,它与E2F转录因子家族的激活成员相互作用,并以E2F依赖的方式增加几种细胞周期调控启动子的活性。我们之前的研究还表明,在大多数转化的人类细胞中EAPP水平会升高。为了研究EAPP这种增加的分子基础,我们分离并研究了EAPP基因5'端的核苷酸序列。计算机分析揭示了一个无TATA框的启动子,带有几个转录因子的假定结合位点,最可能的是Sp1、Sp3和Egr-1。我们可以通过电泳迁移率变动分析、超迁移实验和竞争分析在体外证实这些因子的结合。此外,我们可以通过染色质免疫沉淀分析在体内验证这种结合。为了分析这些转录因子在EAPP表达中的功能,我们用启动子及其截短体进行了报告基因分析。我们发现Sp1和Egr-1刺激EAPP启动子,而Sp3作为一种阻遏物,甚至可以克服激活剂的正向作用。增加Sp3的量也会导致EAPP的强烈降低,但Sp1或Egr-1的过表达仅导致EAPP水平略有升高。我们的结果表明,转化细胞中EAPP水平的升高可能是由于Sp3活性降低引起的,但较高的Sp1活性也可能起作用。